AU565 - Cell Line (ID:50091)
HMS LINCS ID: | 50091 |
Name: | AU565 |
Alternative Names: | AU-565 |
LINCS ID: | LCL-1462 |
Alternative ID: | CLO_0001769 |
Parent Cell Line: | |
Reference Source: | ATCC CRL-2351 |
Organism: | Homo sapiens |
Organ: | breast |
Tissue: | |
Cell Type: | |
Details of Cell Type: | |
Donor Sex: | female |
Donor Age: | |
Donor Ethnicity: | |
Donor Health Status: | |
Disease: | DOID:3458, adenocarcinoma |
Details of Disease: | breast adenocarcinoma |
Production Details: | |
Genetic Modification(s): | none |
Known Mutations: | |
Citation Information for Mutations: | COSS910704 |
Verification Reference Profile: | |
Growth Properties: | adherent |
Recommended Culture Conditions: | From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%. Subculturing: Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks. Subcultivation ratio: A subcultivation ratio of 1:4 to 1:6 is recommended |
Relevant Citations: | |
Usage Note: | |
Comments: | |
Date Publicly Available: | 2012-07-31 |
Most Recent Update: | 2016-04-04 |
Batch Information for HMSL50091-2:
HMS LINCS Batch ID: | 50091-2 |
Provider: | Mario Niepel (Harvard Medical School) |
Provider Catalog ID: | |
Provider Batch ID: | |
Source Information: | Obtained by Mario Niepel (Harvard Medical School) from ATCC as part of the ICBP43 Collection in July, 2010, and distributed to Mohammad Fallahi-Sichani in December of 2012. |
Date Received: | 2012-12 |
HMS QC Outcome: | |
Transient Modification(s): | |
Comments: | |
Date Publicly Available: | 2016-06-06 |
Most Recent Update: | 2016-07-12 |